Bemfola®
ACTIVE PRINCIPLE:
follitropin alfa
INDICATION:
Anovulation
DATE:
27/03/2014
STATUS:
Authorized
Biosimilar medicine authorized by the European Commission
ACTIVE PRINCIPLE:
follitropin alfa
INDICATION:
Anovulation
DATE:
27/03/2014
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.